A new approach to the design and evaluation of T cell vaccines for cancer and infectious disease. [ 2015 - 2017 ]

Research Grant

Researchers: A/Pr Kristen Radford (Principal investigator) ,  A/Pr John Miles ,  A/Pr Mireille Lahoud ,  Prof David Price

Brief description Special white blood cells called dendritic cells teach the immune system to fight cancer and are a key component of therapeutic cancer vaccines. We identified a subtype of human dendritic cell that is predicted to be the most effective at mounting anti-cancer immune responses. We developed a novel antibody specific for these dendritic cells that can be used to deliver the vaccine directly to them and will use this to construct and validate a novel vaccine for cancer and viral infections.

Funding Amount $AUD 394,137.12

Funding Scheme Project Grants

Notes Standard Project Grant